Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

This randomised trial compared platinum-based to anthracycline-based chemotherapy in patients with small-cell lung cancer (limited or extensive stage) and ⩽2 adverse prognostic factors. Patients were randomised to receive six cycles of either ACE (doxorubicin 50 mg/m(2) i.v., cyclophosphamide 1 g/m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Baka, S, Califano, R, Ferraldeschi, R, Aschroft, L, Thatcher, N, Taylor, P, Faivre-Finn, C, Blackhall, F, Lorigan, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527803/
https://www.ncbi.nlm.nih.gov/pubmed/18665190
http://dx.doi.org/10.1038/sj.bjc.6604480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527803/
https://www.ncbi.nlm.nih.gov/pubmed/18665190
http://dx.doi.org/10.1038/sj.bjc.6604480

Ejemplares similares